(A) Maximum intensity projections showing GFP-NOMPC distribution in c3da neurons wild-type control (left) and dTatKO mutant (right) larvae additionally expressing the membrane marker CD4-tdTomato.
(B) S2 cells stably transfected with UAS-GFP-nompC were immunostained with antibodies to GFP and acTb or α-tubulin, as indicated. Images show cells in interphase (left, middle) and during anaphase (right).
(C) S2 cells stably transfected with UAS-GFP-nompC were treated with control RNAi, dTat RNAi, taxol, or tubacin; immunostained using GFP and tubulin antibodies; and the fraction of cells exhibiting NOMPC-microtubule co-localization was visually scored in a blind experiment. Chi-square tests revealed no differences in NOMPC-microtubule co-localization among the different treatments. The number of cells analyzed is shown for each treatment.